MAPK1IP1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.284600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.832000E-01
Normal-vs-Stage2
9.214200E-01
Normal-vs-Stage3
1.733190E-01
Normal-vs-Stage4
1.913360E-01
Stage1-vs-Stage2
1.098230E-01
Stage1-vs-Stage3
1.045220E-01
Stage1-vs-Stage4
1.452340E-02
Stage2-vs-Stage3
7.218400E-02
Stage2-vs-Stage4
1.926580E-01
Stage3-vs-Stage4
1.989760E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.264000E-01
Normal-vs-AfricanAmerican
8.778000E-01
Normal-vs-Asian
6.836800E-01
Caucasian-vs-AfricanAmerican
8.318800E-01
Caucasian-vs-Asian
2.969400E-01
AfricanAmerican-vs-Asian
5.077200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.517000E-01
Normal-vs-Female
8.927400E-01
Male-vs-Female
8.004200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.883200E-01
Normal-vs-Age(41-60Yrs)
4.314600E-01
Normal-vs-Age(61-80Yrs)
8.554200E-01
Normal-vs-Age(81-100Yrs)
1.561580E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.735000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.907800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.538070E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.427800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.97019999995207E-06
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.421500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.764400E-01
Normal-vs-Daily Drinker
7.667400E-01
Normal-vs-Weekly Drinker
9.302400E-01
Normal-vs-Occasional Drinker
6.336200E-01
Normal-vs-Social Drinker
6.686600E-01
Non Drinker-vs-Daily Drinker
6.459600E-01
Non Drinker-vs-Weekly Drinker
4.491000E-01
Non Drinker-vs-Occasional Drinker
4.012500E-02
Non Drinker-vs-Social Drinker
6.271700E-02
Daily Drinker-vs-Weekly Drinker
7.412200E-01
Daily Drinker-vs-Occasional Drinker
1.398810E-01
Daily Drinker-vs-Social Drinker
1.888960E-01
Weekly Drinker-vs-Occasional Drinker
3.388800E-01
Weekly Drinker-vs-Social Drinker
4.063800E-01
Occasional Drinker-vs-Social Drinker
9.008400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.723650E-01
Normal-vs-Grade 2
5.189200E-01
Normal-vs-Grade 3
5.437800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.187600E-01
Grade 1-vs-Grade 3
9.527000E-01
Grade 1-vs-Grade 4
1.723650E-01
Grade 2-vs-Grade 3
4.945400E-01
Grade 2-vs-Grade 4
5.189200E-01
Grade 3-vs-Grade 4
5.437800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.651600E-01
Normal-vs-NonDiabetic
9.250600E-01
Diabetic-vs-NonDiabetic
2.092600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.875200E-01
Normal-vs-NoPancreatitis
9.590000E-01
Pancreatitis-vs-NoPancreatitis
1.051590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.560200E-01
Normal-vs-N1
8.804400E-01
N0-vs-N1
4.774000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.929200E-01
Normal-vs-TP53-NonMutant
8.869800E-01
TP53-Mutant-vs-TP53-NonMutant
6.412800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
